CDSCO clears recombinant live attenuated dengue vaccine for ages 4 to 60 years
India's CDSCO has approved the first dengue vaccine, Qdenga, for individuals aged 4 to 60 after rigorous evaluation.
21 Jul 06:09 · The Hindu
CDSCO clears recombinant live attenuated dengue vaccine for ages 4 to 60 years
India's CDSCO has approved the first dengue vaccine, Qdenga, for individuals aged 4 to 60 after rigorous evaluation.
21 Jul 06:09 · The Hindu
last updated on 21 Jul 17:08